Canada approves Pfizer/BioNTech's COVID-19 vaccine, first shots expected next week
By Allison Martell and Steve Scherer TORONTO/OTTAWA (Reuters) - Canada on Wednesday approved its first COVID-19 vaccine, clearing the way for doses of the Pfizer Inc and BioNTech SE shots to be delivered and administered across the country. Canada is the third country after the United Kingdom and Bahrain to give the green light to the Pfizer-BioNTech vaccine. Canada has a temporary accelerated drug review system very similar to the U.S.
COVID-19 vaccine, first shots expected next week" src="https://images.firstpost.com/wp-content/uploads/reuters/12-2020/10/2020-12-09T163020Z_1_LYNXMPEGB81BJ_RTROPTP_2_HEALTH-CORONAVIRUS-EUROPE-VACCINES.jpg" alt="Canada approves PfizerBioNTechs COVID19 vaccine first shots expected next week" width="300" height="225" />
By Allison Martell and Steve Scherer
TORONTO/OTTAWA (Reuters) - Canada on Wednesday approved its first COVID-19 vaccine, clearing the way for doses of the Pfizer Inc and BioNTech SE shots to be delivered and administered across the country.
Canada is the third country after the United Kingdom and Bahrain to give the green light to the Pfizer-BioNTech vaccine.
Canada has a temporary accelerated drug review system very similar to the U.S. Food and Drug Administration's emergency use authorizations.
"The approval of the vaccine is supported by evidence that it is safe, effective and of good quality," regulator Health Canada said in a statement. It has initially been authorized for use in people 16 years of age or older.
The news comes a day before a panel of advisers to the FDA is set to review and recommend whether the U.S. agency should authorize use of the Pfizer vaccine, and a day after UK citizens become the first in the world to get the shots outside of clinical trials.
Canada will receive an early shipment of up to 249,000 doses of Pfizer's vaccine this year. The province of Saskatchewan said on Wednesday it expected to receive enough doses for 1,950 people by Tuesday to inoculate healthcare workers in direct contact with COVID-19 patients.
"Today's decision from Health Canada is a historic moment in our collective fight against the COVID-19 pandemic and is a major step towards returning to normalcy in Canada," said Cole Pinnow, president of Pfizer Canada, in a statement.
The UK, on Dec. 2, was first to approve the two-dose Pfizer vaccine, which in a large clinical trial was 95% effective at preventing illness.
Pfizer is responsible for shipping its vaccine, which requires ultra-cold storage, to warehouses across Canada.
Canada has a firm order for 20 million doses of the vaccine, enough to inoculate 10 million people, with options to buy up to 56 million more.
For the most part, provincial and territorial health systems will administer the shot, for free, across the country. They will have final say over how to use scarce early supplies in their jurisdictions.
According to preliminary guidance published by the federal government in early November, vulnerable people and those who look after them are high priority, including long-term care residents and some healthcare workers.
Regulators have received rolling applications for three other experimental vaccines, from Moderna Inc, AstraZeneca Plc and Johnson & Johnson.
Of those, the Moderna vaccine is farthest along, having completed pivotal trials showing it to be 94.1% effective at preventing illness and 100% at preventing severe COVID-19 .
Officials have said they expect to receive six million doses of Pfizer and Moderna vaccines before the end of March 2021. Each vaccine requires two doses given about three weeks apart.
(Reporting by Allison Martell in Toronto and Steve Scherer in Ottawa; additional reporting by David Ljunggren in Ottawa and Rod Nickel in Winnipeg; editing by Bill Berkrot)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) -Moderna Inc said on Monday it would produce at least 600 million doses of its COVID-19 vaccine in 2021, up by 100 million doses from its previous forecast, as the United States continues to roll-out the vaccine. The company was working to invest and hire in order to deliver up to 1 billion doses this year, the higher end of its production forecast, it said
WARSAW (Reuters) - A skating rink owner in the Polish city of Szczecin believes he has found a way to keep his business open despite coronavirus restrictions - operate as a flower shop instead. His plan is simple - the customer has to purchase access to the flower "warehouse", then chooses from a box of flowers in the middle of the rink. "You can jump, crawl or go on all fours ..
By Reuters Staff SANAA (Reuters) - Paralysed and severely malnourished, seven-year-old Faid Samim lies curled up on a hospital bed in the Yemeni capital Sanaa, having barely survived the journey there. "He was almost gone when he arrived but thank God we were able to do what was necessary and he started improving. He is suffering from CP (cerebral palsy) and severe malnutrition," said Rageh Mohammed, the supervising doctor of the Al-Sabeen hospital's malnutrition ward.